Idiopathic Pulmonary Fibrosis- Free CEU for Respiratory Therapists

ipfGuiding Patients Through Decisions in Idiopathic Pulmonary Fibrosis (IPF): The Respiratory Therapists’ Role– Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quailty of life and diminishes life expectancy. New therapies are available that slow function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. This program will discuss the prevalence, signs and symptoms, and diagnostic criteria for IPF as well as compare and contrast available therapies and formulate strategies for comprehensive management of symptoms.
Outline the prevalence, signs and symptoms, and diagnostic criteria for IPF.
Compare and contrast available therapies for IPF.
Formulate strategies for comprehensive management of symptoms.
Effectively counsel IPF patients on available therapies and supportive care.
Identify patients with IPF who may benefit from intensification of therapy.

1.0 Free CEUs for Respiratory Therapists

Expires 12/31/17

achlme logo
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Advertisements
This entry was posted in Respiratory Therapy and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s